NCT05766488View on ClinicalTrials.gov

Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Type 2 Diabetes
Interventions
DEVICE

Continuous Glucose Monitor (CGM)

A Freestyle Libre 2 continuous glucose monitor (CGM) will be provided in the experimental arm of this study for 6 months.

DEVICE

Self-monitoring Blood Glucose (SMBG)

A traditional glucometer device will be assigned in the active comparitor arm of this study for 6 months.

Trial Locations (1)

68198-7400D

Nebraska Medicine, Omaha

All Listed Sponsors
collaborator

Great Plains IDeA-CTR

UNKNOWN

lead

University of Nebraska

OTHER